Unknown

Dataset Information

0

Usenamine A triggers NLRP3/caspase-1/GSDMD-mediated pyroptosis in lung adenocarcinoma by targeting the DDX3X/SQSTM1 axis.


ABSTRACT:

Background

Usenamine A (C18H17NO6) is a newly developed, natural anticancer drug that reportedly exerts low toxicity. The therapeutic efficacy and underlying mechanisms of usenamine A in lung adenocarcinoma (LUAD) remain poorly understood. We aimed to explore the therapeutic effects and molecular mechanisms through which usenamine A inhibits LUAD tumorigenesis.

Methods

We used LUAD cell lines H1299 and A549 in the present study. CCK-8 and colony formation assays were performed to analyze cell proliferation. Cell migration, invasion, and apoptosis were evaluated using wound-healing, transwell, and flow cytometric assays, respectively. Levels of reactive oxygen species were measured using a DCFH-DA probe. Inflammatory factors (lactate dehydrogenase, interleukin [IL]-1β, and IL-18) were detected using enzyme-linked immunosorbent assays. Western blotting was performed to determine the expression of NOD-like receptor pyrin 3 (NLRP3)/caspase-1/gasdermin D (GSDMD) pathway-related proteins. Pyroptosis was detected using transmission electron microscopy. The interaction and co-localization of DDX3X and sequestosome 1 (SQSTM1) were identified using co-immunoprecipitation and immunofluorescence assays, respectively. For in vivo assessment, we established a xenograft model to validate the usenamine A-mediated effects and mechanisms of action in LUAD.

Results

Usenamine A inhibited the proliferation, migration, and invasion of LUAD cells. Furthermore, usenamine A induced NLRP3/caspase-1/GSDMD-mediated pyroptosis in LUAD cells. Usenamine A upregulated DDX3X expression to trigger pyroptosis. DDX3X interacted with SQSTM1, which is responsible for inducing pyroptosis. In vivo, usenamine A suppressed LUAD tumorigenesis by triggering NLRP3/caspase-1/GSDMD-mediated pyroptosis via the upregulation of the DDX3X/SQSTM1 axis.

Conclusions

Usenamine A was found to induce NLRP3/caspase-1/GSDMD-mediated pyroptosis in LUAD by upregulating the DDX3X/SQSTM1 axis.

SUBMITTER: Li M 

PROVIDER: S-EPMC10866397 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Usenamine A triggers NLRP3/caspase-1/GSDMD-mediated pyroptosis in lung adenocarcinoma by targeting the DDX3X/SQSTM1 axis.

Li Min M   Wu Rongrong R   Wang Le L   Zhu Dongyi D   Liu Shinan S   Wang Ruolan R   Deng Chaowen C   Zhang Shenglin S   Chen Min M   Lu Ruojin R   Zhu Hongxing H   Mo Mengting M   He Xiaoqiong X   Luo Zhuang Z  

Aging 20240123 2


<h4>Background</h4>Usenamine A (C<sub>18</sub>H<sub>17</sub>NO<sub>6</sub>) is a newly developed, natural anticancer drug that reportedly exerts low toxicity. The therapeutic efficacy and underlying mechanisms of usenamine A in lung adenocarcinoma (LUAD) remain poorly understood. We aimed to explore the therapeutic effects and molecular mechanisms through which usenamine A inhibits LUAD tumorigenesis.<h4>Methods</h4>We used LUAD cell lines H1299 and A549 in the present study. CCK-8 and colony fo  ...[more]

Similar Datasets

| S-EPMC11868043 | biostudies-literature
| S-EPMC9050284 | biostudies-literature
| S-EPMC11479918 | biostudies-literature
| S-EPMC10488171 | biostudies-literature
| S-EPMC10757784 | biostudies-literature
| S-EPMC7201508 | biostudies-literature
| S-EPMC8918356 | biostudies-literature
| S-EPMC7017302 | biostudies-literature
| S-EPMC11519391 | biostudies-literature
| S-EPMC7878072 | biostudies-literature